ly aggressive blood pressure lowering is not without
risk in the usually elderly with a DFU and those with
multiple diabetes related complications and comorbidities. Therefore, in these people blood
pressures < 140/90 mmHg are recommended, but in
younger individuals (e.g., < 65 years) and with a small risk
of adverse effects of the treatment, lower target levels
might be considered.
Lipid goals. The ADA and